Korea is negotiating with mRNA technology manufacturers including Pfizer and Moderna, ready to provide a billion dose immediately.

A senior official today reveals the MRNA MRNA Technology Vaccine Planning Plan.

Vaccine Covid-19 produces MRNA technology of Moderna.

Korea has reached a Domestic Production Agreement three types of Vaccine Covid-19 as Russian Astrazeneca, Novavax and Vaccine of Russia.

We regularly organize negotiations with major pharmaceutical companies in manufacturing Vaccine MRNA, Lee Kang-Ho, General Director of the Global Vaccine Center of the Korean Ministry of Health, said.

There are only a few Vaccine MRNA manufacturers, Pfizer, Moderna, Corevac and Biontech.

It is unclear the progress of negotiations, as well as negotiation results and implementation time.

Biotntech declined to comment, Moderna and Corevac did not answer the comment request.

Lee said Korea was able to produce a billion dose of Vaccine Covid-19 according to MRNA technology immediately, but refused to name local vaccine manufacturers to be qualified.

Hanmi confirmed a large capacity production line for Sanofi diabetes and could use this line to produce Vaccine Covid-19 by the project with Sanofi being postponed.

Quratis, the company that produces tuberculosis vaccine, said new factory opened last year can be used to produce Vaccine mRNA.

Vaccine Covid-19 developed based on mRNA technology (genetic information) is covered with a layer of nano lipid (fat) of cells.